Orodispersible minitablets of enalapril for use in children with heart failure (LENA): Rationale and protocol for a multicentre pharmacokinetic bridging study and follow-up safety study

This publication has 27 references indexed in Scilit:

• An integrated Physiology-Based Model for the Interaction of RAA System Biomarkers With Drugs
  Journal of Cardiovascular Pharmacology, 2012
• Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study
  Archives of Disease in Childhood, 2012
• Determination of enalapril and enalaprilat in small human serum quantities for pediatric trials by HPLC–tandem mass spectrometry
  Biomedical Chromatography, 2011
• Epidemiology of Heart Failure in a Tertiary Pediatric Center
  Clinical Cardiology, 2008
• Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants
  Journal of Perinatal Medicine, 2008
• New-Onset Heart Failure Due to Heart Muscle Disease in Childhood
  Circulation, 2008
• ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
  JACC, 2005
• A Double‐Blind, Placebo‐Controlled, Dose‐Response Study of the Effectiveness and Safety of Enalapril for Children with Hypertension
  The Journal of Clinical Pharmacology, 2002
• Orally administered enalapril for infants with congestive heart failure: A dose-finding study
  The Journal of Pediatrics, 1989
• Plasma norepinephrine levels in infants and children with congestive heart failure
  The American Journal of Cardiology, 1987